334 related articles for article (PubMed ID: 29209873)
1.
Wang J; Fan T; He Y; Chen X; Fan Z; Xie Y; Wang T; Li J; Ouyang T
Breast Cancer Res Treat; 2018 Apr; 168(2):365-370. PubMed ID: 29209873
[TBL] [Abstract][Full Text] [Related]
2. [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
Wang XJ; Lin BH; Yang Z; Ouyang T; Li JF; Xu B; Zhang Y; Zhang MY
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):200-3. PubMed ID: 16875605
[TBL] [Abstract][Full Text] [Related]
3. Higher axillary lymph node metastasis burden in breast cancer patients with positive preoperative node biopsy: may not be appropriate to receive sentinel lymph node biopsy in the post-ACOSOG Z0011 trial era.
Liang Y; Chen X; Tong Y; Zhan W; Zhu Y; Wu J; Huang O; He J; Zhu L; Li Y; Chen W; Shen K
World J Surg Oncol; 2019 Feb; 17(1):37. PubMed ID: 30786903
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
[TBL] [Abstract][Full Text] [Related]
5. The clinical utility of combining pre-operative axillary ultrasonography and fine needle aspiration cytology with radionuclide guided sentinel lymph node biopsy in breast cancer patients with palpable axillary lymph nodes.
Usmani S; Ahmed N; Al Saleh N; abu Huda F; Amanguno HG; Amir T; al Kandari F
Eur J Radiol; 2015 Dec; 84(12):2515-20. PubMed ID: 26474908
[TBL] [Abstract][Full Text] [Related]
6. Clinical Evaluation of 99mTc-Rituximab for Sentinel Lymph Node Mapping in Breast Cancer Patients.
Li N; Wang X; Lin B; Zhu H; Liu C; Xu X; Zhang Y; Zhai S; OuYang T; Li J; Yang Z
J Nucl Med; 2016 Aug; 57(8):1214-20. PubMed ID: 26985055
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy in Chinese patients with large operable breast cancer (≥4 cm): A decade's experience from a single institution.
Yang Y; He Y; Fan Z; Ouyang T
Breast; 2017 Dec; 36():20-24. PubMed ID: 28869832
[TBL] [Abstract][Full Text] [Related]
8. Axillary staging for breast cancer during pregnancy: feasibility and safety of sentinel lymph node biopsy.
Han SN; Amant F; Cardonick EH; Loibl S; Peccatori FA; Gheysens O; Sangalli CA; Nekljudova V; Steffensen KD; Mhallem Gziri M; Schröder CP; Lok CAR; Verest A; Neven P; Smeets A; Pruneri G; Cremonesi M; Gentilini O;
Breast Cancer Res Treat; 2018 Apr; 168(2):551-557. PubMed ID: 29235045
[TBL] [Abstract][Full Text] [Related]
9. Comparative research on
Zhang JJ; Zhang WC; An CX; Li XM; Ma L
BMC Cancer; 2019 Oct; 19(1):956. PubMed ID: 31615471
[TBL] [Abstract][Full Text] [Related]
10. Is it always necessary to perform an axillary lymph node dissection after neoadjuvant chemotherapy for breast cancer?
Osorio-Silla I; Gómez Valdazo A; Sánchez Méndez JI; York E; Díaz-Almirón M; Gómez Ramírez J; Rivas Fidalgo S; Oliver JM; Álvarez CM; Hardisson D; Díaz Miguel M; Lobo F; Díaz Domínguez J
Ann R Coll Surg Engl; 2019 Mar; 101(3):186-192. PubMed ID: 30421628
[TBL] [Abstract][Full Text] [Related]
11. Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.
Shigematsu H; Nishina M; Yasui D; Hirata T; Ozaki S
World J Surg Oncol; 2019 Feb; 17(1):41. PubMed ID: 30797231
[TBL] [Abstract][Full Text] [Related]
12. Late Axillary Recurrence After Negative Sentinel Lymph Node Biopsy is Uncommon.
Matsen C; Villegas K; Eaton A; Stempel M; Manning A; Cody HS; Morrow M; Heerdt A
Ann Surg Oncol; 2016 Aug; 23(8):2456-61. PubMed ID: 26957506
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer larger than 2.5 cm with tumor-free radioisotope-hot sentinel nodes has higher risk of non-hot axillary lymph node metastasis.
Liu YL; Kuo WL; Lo YF; Tsai HP; Shen SC; Yu CC; Chou HH; Chu CH; Chen SC
Biomed J; 2022 Apr; 45(2):396-405. PubMed ID: 35562283
[TBL] [Abstract][Full Text] [Related]
14. "Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients".
van Wely BJ; van den Wildenberg FJ; Gobardhan P; van Dalen T; Borel Rinkes IH; Theunissen EB; Wijsman JH; Ernst M; van der Pol CC; Madsen EV; Vles WJ; Wauters CA; de Wilt JH; Strobbe LJ
Eur J Surg Oncol; 2012 Oct; 38(10):925-31. PubMed ID: 22633152
[TBL] [Abstract][Full Text] [Related]
15. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer hormone receptor negativity, triple-negative type, mastectomy and not receiving adjuvant radiotherapy were associated with axillary recurrence after sentinel lymph node biopsy.
Sekine C; Nakano S; Mibu A; Otsuka M; Oinuma T; Takeyama H
Asian J Surg; 2020 Jan; 43(1):148-153. PubMed ID: 31153730
[TBL] [Abstract][Full Text] [Related]
17. Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up.
Kahler-Ribeiro-Fontana S; Pagan E; Magnoni F; Vicini E; Morigi C; Corso G; Intra M; Canegallo F; Ratini S; Leonardi MC; La Rocca E; Bagnardi V; Montagna E; Colleoni M; Viale G; Bottiglieri L; Grana CM; Biasuz JV; Veronesi P; Galimberti V
Eur J Surg Oncol; 2021 Apr; 47(4):804-812. PubMed ID: 33092968
[TBL] [Abstract][Full Text] [Related]
18.
Li N; Zhou X; Zhu H; Wang F; Guo R; Zhang Y; Song Y; Zhai S; Xie Q; Liu J; Li Z; Yang Z
Ann Nucl Med; 2023 Mar; 37(3):189-197. PubMed ID: 36586034
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of axillary recurrences after negative sentinel lymph node biopsy: effect on prognosis and survival.
Bulte JP; van Wely BJ; Kasper S; Kuijt G; van den Wildenberg FJ; Strobbe LJ; de Wilt JH
Breast Cancer Res Treat; 2013 Jul; 140(1):143-9. PubMed ID: 23793602
[TBL] [Abstract][Full Text] [Related]
20. Factors Predictive of Sentinel Lymph Node Involvement in Primary Breast Cancer.
Malter W; Hellmich M; Badian M; Kirn V; Mallmann P; Krämer S
Anticancer Res; 2018 Jun; 38(6):3657-3662. PubMed ID: 29848724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
